Literature DB >> 32610064

Synthesis of cordycepin: Current scenario and future perspectives.

Liyang Yang1, Guilan Li1, Zhi Chai1, Qiang Gong1, Jianquan Guo2.   

Abstract

Cordyceps genus, such as C. militaris and C. kyushuensis, is a source of a rare traditional Chinese medicine that has been used for the treatment of numerous chronic and malignant diseases. Cordycepin, 3'-deoxyadenosine, is a major active compound found in most Cordyceps. Cordycepin exhibits a variety of biological activities, including anti-tumor, immunomodulation, antioxidant, and anti-aging, among others, which could be applied in health products, medicine, cosmeceutical etc. fields. This review focuses on the synthesis methods for cordycepin. The current methods for cordycepin synthesis involve chemical synthesis, microbial fermentation, in vitro synthesis and biosynthesis; however, some defects are unavoidable and the production is still far from the demand of cordycepin. For the future study of cordycepin synthesis, based on the illumination of cordycepin biosynthesis pathway, genetical engineering of the Cordyceps strain or introducing microbes by virtue of synthetic biology will be the great potential strategies for cordycepin synthesis. This review will aid the future synthesis of the valuable cordycepin.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biosynthetic pathway; Cordycepin; Cordyceps militaris; Synthesis

Year:  2020        PMID: 32610064     DOI: 10.1016/j.fgb.2020.103431

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  2 in total

Review 1.  Research Progress on Cordycepin Synthesis and Methods for Enhancement of Cordycepin Production in Cordyceps militaris.

Authors:  Li Wang; Huanhuan Yan; Bin Zeng; Zhihong Hu
Journal:  Bioengineering (Basel)       Date:  2022-02-11

2.  Improvement of cordycepin production by an isolated Paecilomyces hepiali mutant from combinatorial mutation breeding and medium screening.

Authors:  Xue Cai; Jie-Yi Jin; Bo Zhang; Zhi-Qiang Liu; Yu-Guo Zheng
Journal:  Bioprocess Biosyst Eng       Date:  2021-07-15       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.